Life Molecular Imaging Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Life Molecular Imaging Ltd. - overview
Established
2012
Location
Fareham, -, UK
Primary Industry
Pharmaceuticals
About
Founded in 2012 and based in Fareham, UK, Life Molecular Imaging Ltd. operates as a pharmaceutical company that develops PET radiopharmaceuticals for imaging of neurodegenerative and cardiovascular diseases. Life Molecular Imaging’s primary product is Neuraceq®, a diagnostic agent used in PET imaging to assess amyloid plaques in the brain, which are indicative of Alzheimer's disease. The company focuses on the research and deployment of advanced molecular imaging agents, also known as radiopharmaceuticals.
These smart chemicals are meant for use in specific tissues, organs, or molecular processes, delivering information about the physiological, cellular, and molecular state of the body. Life Molecular Imaging improves illness detection and diagnosis by employing labelled tracers and positron emission tomography (PET), a noninvasive imaging technology. The company's molecular imaging agents are labelled with positron-emitting radionuclides such 18F. Following intravenous injections these drugs spread throughout the body, collecting in disease-affected areas.
This method enables for the visualization of disease in its early phases. Some of the firm’s partners are Sofie, Alliance Medical, Seibersdorf Laboratories, IsoLogic, Positronpharma, Itelpharma, AC Immune, and others.
Current Investors
Alzheimer's Drug Discovery Foundation
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development, Specialty Pharmaceuticals
Website
www.life-mi.com/
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.